SIA
CLB icon

Sit Investment Associates’s Core Laboratories CLB Stock Holding History

Sit Investment Associates’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-10,250
Closed -$1.23M – 430
2014
Q4 		$1.23M Sell
10,250
-830
-7% -$109K 0.02% 307
2014
Q3 		$1.62M Sell
11,080
-5,700
-34% -$880K 0.03% 290
2014
Q2 		$2.8M Sell
16,780
-4,525
-21% -$805K 0.05% 268
2014
Q1 		$4.23M Hold
21,305
– – 0.07% 215
2013
Q4 		$4.07M Sell
21,305
-500
-2% -$93.1K 0.07% 209
2013
Q3 		$3.69M Hold
21,805
– – 0.07% 209
2013
Q2 		$3.31M Buy
+21,805
New +$3.09M 0.07% 216

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
WP
Wedgewood Partners St Louis, Missouri $484M AUM 14.59% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WI
WHV Investments San Francisco, California $187M AUM 14.29% 1-Year Est. Return

Sit Investment Associates's CLB Position: Q1 2015 in Review

Sit Investment Associates sold out of Core Laboratories (CLB) in Q1 2015, closing a stake of 10,250 shares — an estimated $1.23M sold.

Sit Investment Associates first reported a position in CLB in Q2 2013 and held it in 7 quarters. The position peaked at $4.23M in Q1 2014. 347 funds tracked by Wall St. Rank hold CLB as of Q1 2015.

  • Sit Investment Associates reported no remaining Core Laboratories position as of Q1 2015 after selling out during the quarter.
  • Sit Investment Associates sold 10,250 Core Laboratories shares in Q1 2015, an estimated $1.23M.
  • Sit Investment Associates first reported a position in Core Laboratories in Q2 2013 and held it in 7 quarters.
  • Sit Investment Associates's Core Laboratories position peaked at $4.23M in Q1 2014.
  • 347 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2015.

Based on Sit Investment Associates's 13F filing for Q1 2015, filed 30 Apr 2015.